ELECSYS CA 19-9
Received Apr 24, 2025 · Event occurred Apr 4, 2025
Report 1823260-2025-01262 · MDR key 21900096
Device
Generic name
Test, Carbohydrate Antigen (ca19-9)
Manufacturer
Roche DiagnosticsCatalog number
07027028214
Lot number
820906
Product problems
- Incorrect Measurement
- Non Reproducible Results
- Incorrect Measurement
- Non Reproducible Results
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
THE COBAS E 801 ANALYTICAL UNIT SERIAL NUMBERS WERE (B)(6). THE INVESTIGATION IS ONGOING.
Description of Event or Problem
THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS CA 19-9 RESULTS FROM TWO COBAS E 801 ANALYTICAL UNITS. SAMPLE 1 INITIAL RESULT WAS 50.9 IU/ML FROM SERIAL NUMBER (B)(6). THE RESULTS WERE 63.9 IU/ML AND OVER 1000 IU/ML FROM SERIAL NUMBER (B)(6). THE REPEAT RESULT FROM EACH SERIAL NUMBER WAS 18 IU/ML. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS RECENTRIFUGED, AND THE RESULT FROM EACH SERIAL NUMBER WAS 281 IU/ML. ON (B)(6) 2025, SAMPLE 2 INITIAL RESULT FROM SERIAL NUMBER (B)(6) WAS 38.8 IU/ML. THE RESULT FROM SERIAL NUMBER (B)(6) WAS 29 IU/ML. THE THIRD RESULT WAS 28.9 IU/ML, BUT IT WAS NOT KNOWN WHICH ANALYZER GENERATED THIS RESULT.
Additional Manufacturer Narrative
THE FIELD SERVICE ENGINEER CHECKED THE ANALYZER AND FOUND NO ISSUES. CALIBRATION AND QC DATA WERE ACCEPTABLE. REPEATABILITY, ACCURACY, AND PERFORMANCE OF THE REAGENT WERE FOUND TO BE ACCEPTABLE. THE INVESTIGATION DETERMINED THE EVENT WAS CONSISTENT WITH PRE-ANALYTICAL HANDLING ISSUES AT THE CUSTOMER SITE. CORRECT PRE-ANALYTIC SAMPLE HANDLING IS WITHIN THE CUSTOMER'S RESPONSIBILITY. THERE IS NO EVIDENCE TO SUGGEST A MALFUNCTION OF THE DEVICE.